All In MedTech

Device Trial Radar · NCT05301140

Vivistim Registry for Paired VNS Therapy (GRASP)

Last checked: Nov 20, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

1,000

Planned (sponsor's estimate)

Start

Mar 15, 2023

Primary completion

Dec 31, 2028

Study completion Dec 31, 2028

Sponsor

Lead sponsor
MicroTransponder Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 29, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment. Before and after Vivistim System implant, patient data will be collected and reported throughout the therapy process. Physicians or sites will receive appropriate remuneration for the effort and cost involved in collecting and transmitting this data to MicroTransponder Inc.

Conditions

  • Upper Extremity Problem

Interventions

  • Vivistim SystemDevice

    VNS Paired with rehabilitation movements

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Fugl Meyer Assessment (FM-A)Time frame: 6 months
  2. Wolf Motor Function Test (WMFT)Time frame: 6 months

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • Advent Health Orlando

    Orlando, Florida · Recruiting

  • Alexian Brothers Health System

    Elk Grove Village, Illinois · Recruiting

  • Ascension Alexian Brothers Rehabilitation Hospital

    Elk Grove Village, Illinois · Recruiting

13 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.